Howze Yalonda
- SEC CIK
- 0001828153
No open-market purchases or sales filed in the past year.
Current role at each company
- GBIO Generation Bio Co.INTERIM CEO AND PRESIDENTas of Feb 9, 2026
- CDAK Codiak BioSciences, Inc.See Remarksas of Mar 30, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Howze Yalonda as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CDAK Codiak BioSciences, Inc.
See Remarks3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 (view filing)6:01 PM ET | Mar 30 | Same day | Howze YalondaSee Remarks | SSale | −1.63K | $0.1955 | −$318.27 | −17.9%7.46K after | |
| Feb 21, 2023 (view filing) | Aug 17, 2022-Feb 17, 2023 | 188 daysLate | Howze YalondaSee Remarks | SSale | −3.12K | $1.38 | −$4.29K | −25.5%9.09K after | 2 lots |
| Jan 23, 2023 (view filing) | Jan 20 | 3 days | Howze YalondaSee Remarks | SSale | −1.51K | $0.58 | −$876.96 | −37.8%2.49K after |